A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

Completed

• Conditions: Schizophrenia

• Registration Number: NCT01214135
• Lead Sponsor: AstraZeneca

Brief Summary

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-09-24
• Study Start: 2010-10
• Study First Submitted QC: 2010-10-01
• Study First Posted: 2010-10-04
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2011-01
• Last Update Submitted: 2011-01-10
• Last Update Posted: 2011-01-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Diagnosis of schizophrenia.
• At least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 - 30th of September 2010).
• Hospitalization due to psychotic symptoms at any time during the study period (1st of July 2009 - 30th of September 2010) and with admission and discharge dates available.

Exclusion Criteria

• Participation in a clinical trial during the study period.
• Treatment in forensic care according to LRV ("Lagen om Rättspsykiatrisk Vård").

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia	every day for the time period of 15 Oct to 31 Dec 2010

Secondary Outcome Measures

Name	Time	Method
To investigate comorbidities of patients with schizophrenia receiving Seroquel XR and IR	every day for the time period of 15 Oct to 31 Dec 2010
To investigate whether Seroquel XR and Seroquel IR are used to treat different types of inpatients with schizophrenia by evaluation of patient characteristics	every day for the time period of 15 Oct to 31 Dec 2010
To investigate the treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR	every day for the time period of 15 Oct to 31 Dec 2010

Trial Locations

Locations (1)

Research Site; 🇸🇪 Öjebyn, Sweden